Dual targeting of HER2-positive breast cancer with trastuzumab emtansine and pertuzumab: Understanding clinical trial results
- Ocaña, A.
- Amir, E.
- Pandiella, A.
ISSN: 1949-2553
Argitalpen urtea: 2018
Alea: 9
Zenbakia: 61
Orrialdeak: 31915-31919
Mota: Berrikuspena